BMRN RSI Chart
Last 7 days
4.9%
Last 30 days
9.1%
Last 90 days
-2.1%
Trailing 12 Months
-7.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 2.2B | 2.2B | 2.3B | 2.4B |
2022 | 1.9B | 1.9B | 2.0B | 2.1B |
2021 | 1.8B | 1.9B | 1.8B | 1.8B |
2020 | 1.8B | 1.8B | 1.9B | 1.9B |
2019 | 1.5B | 1.5B | 1.6B | 1.7B |
2018 | 1.4B | 1.4B | 1.5B | 1.5B |
2017 | 1.2B | 1.2B | 1.3B | 1.3B |
2016 | 923.7M | 973.7M | 1.0B | 1.1B |
2015 | 801.0M | 859.3M | 891.7M | 889.9M |
2014 | 572.1M | 627.1M | 666.8M | 749.6M |
2013 | 512.0M | 524.8M | 533.5M | 548.5M |
2012 | 448.6M | 461.9M | 476.6M | 500.7M |
2011 | 400.8M | 419.5M | 435.1M | 441.4M |
2010 | 335.6M | 344.8M | 361.7M | 376.3M |
2009 | 0 | 305.9M | 315.3M | 324.7M |
2008 | 0 | 0 | 0 | 296.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 12, 2024 | bienaime jean jacques | sold | -1,825,200 | 91.26 | -20,000 | - |
Apr 12, 2024 | bienaime jean jacques | acquired | 1,262,000 | 63.1 | 20,000 | - |
Apr 11, 2024 | bienaime jean jacques | acquired | 1,262,000 | 63.1 | 20,000 | - |
Apr 11, 2024 | bienaime jean jacques | sold | -1,819,800 | 90.99 | -20,000 | - |
Apr 10, 2024 | burkhart erin | sold | -205,740 | 90.00 | -2,286 | gvp, chief accounting officer |
Mar 28, 2024 | davis george eric | sold | -2,173,340 | 88.34 | -24,602 | evp, chief legal officer |
Mar 18, 2024 | slamon dennis | acquired | 797,000 | 79.7 | 10,000 | - |
Mar 18, 2024 | slamon dennis | sold (taxes) | -797,033 | 83.81 | -9,510 | - |
Mar 18, 2024 | burkhart erin | sold (taxes) | -31,199 | 83.87 | -372 | gvp, chief accounting officer |
Mar 15, 2024 | guyer charles greg | acquired | - | - | 10,550 | evp, chief technical officer |
Which funds bought or sold BMRN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 12, 2024 | DNB Asset Management AS | added | 16.32 | 3,857,560 | 75,740,100 | 0.40% |
Apr 12, 2024 | AdvisorNet Financial, Inc | reduced | -97.47 | -37,309 | 873 | -% |
Apr 12, 2024 | INSPIRION WEALTH ADVISORS, LLC | added | 0.55 | -131,776 | 1,131,400 | 0.19% |
Apr 12, 2024 | HARBOR INVESTMENT ADVISORY, LLC | unchanged | - | -15,300 | 147,168 | 0.01% |
Apr 12, 2024 | First PREMIER Bank | new | - | 11,000 | 11,000 | -% |
Apr 12, 2024 | GATEWAY INVESTMENT ADVISERS LLC | added | 65.21 | 617,789 | 1,862,090 | 0.02% |
Apr 12, 2024 | WASHINGTON CAPITAL MANAGEMENT, INC | unchanged | - | -59,020 | 567,710 | 0.46% |
Apr 12, 2024 | Financial Synergies Wealth Advisors, Inc. | sold off | -100 | -414 | - | -% |
Apr 12, 2024 | Riverview Trust Co | new | - | 18,429 | 18,429 | 0.01% |
Apr 11, 2024 | SALEM INVESTMENT COUNSELORS INC | sold off | -100 | -13,981 | - | -% |
Unveiling BioMarin Pharmaceutical Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to BioMarin Pharmaceutical Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 39.7B | 6.8B | -8.42 | 5.79 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.6B | 1.8B | -42.25 | 10.17 | ||||
BMRN | 17.3B | 2.4B | 103 | 7.14 | ||||
INCY | 12.0B | 3.7B | 20.07 | 3.25 | ||||
MID-CAP | ||||||||
APLS | 6.2B | 396.6M | -11.74 | 15.65 | ||||
BBIO | 4.5B | - | -6.94 | 60.35 | ||||
AXSM | 3.2B | 270.6M | -13.52 | 11.95 | ||||
ARWR | 3.0B | 240.7M | -10.03 | 12.36 | ||||
ACAD | 2.8B | 726.4M | -45.41 | 3.83 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 25.42 | 4.56 | ||||
NVAX | 576.6M | 983.7M | -1.06 | 0.59 | ||||
CRBP | 448.6M | 881.7K | -10.06 | 466.16 | ||||
INO | 256.8M | 4.9M | -1.9 | 52.78 | ||||
IBIO | 6.7M | 2.1M | -0.25 | 2.14 |
BioMarin Pharmaceutical Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 11.2% | 646 | 581 | 595 | 596 | 538 | 505 | 534 | 519 | 450 | 409 | 502 | 486 | 452 | 477 | 429 | 502 | 454 | 461 | 388 | 401 | 353 |
Cost Of Revenue | 8.6% | 135 | 125 | 128 | 127 | 127 | 116 | 123 | 117 | 120 | 104 | 127 | 120 | 126 | 189 | 98.00 | 111 | 96.00 | 97.00 | 77.00 | 89.00 | 75.00 |
Costs and Expenses | 13.7% | 632 | 556 | 536 | 537 | 562 | 508 | 495 | 382 | 516 | 462 | 490 | 461 | 504 | 533 | 470 | 397 | 464 | 457 | 429 | 455 | 391 |
S&GA Expenses | 22.8% | 275 | 224 | 215 | 223 | 246 | 217 | 197 | 195 | 218 | 183 | 184 | 174 | 196 | 179 | 175 | 187 | 188 | 170 | 161 | 162 | 164 |
R&D Expenses | 7.8% | 206 | 191 | 177 | 172 | 173 | 158 | 158 | 161 | 161 | 158 | 161 | 149 | 157 | 147 | 182 | 142 | 173 | 173 | 186 | 184 | 175 |
EBITDA Margin | 11.2% | 0.12* | 0.11* | 0.09* | 0.08* | 0.12* | 0.10* | 0.08* | 0.08* | 0.02* | 0.02* | 0.02* | 0.00* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 61.4% | 6.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 10.00 | 8.00 | 7.00 | 7.00 | 3.00 | 7.00 | 7.00 | 8.00 |
Income Taxes | -181.2% | -1.05 | 1.00 | 15.00 | 6.00 | -17.31 | 5.00 | 7.00 | 13.00 | -8.68 | -9.67 | 1.00 | 6.00 | -63.89 | -846 | -13.09 | 20.00 | -24.80 | -45.21 | -4.46 | 4.00 | -39.66 |
Earnings Before Taxes | -53.6% | 19.00 | 42.00 | 71.00 | 57.00 | -17.56 | -1.90 | 35.00 | 134 | -66.57 | -46.16 | 14.00 | 23.00 | -46.86 | -61.22 | -42.27 | 101 | -9.78 | 10.00 | -41.89 | -52.96 | -43.31 |
EBT Margin | 18.7% | 0.08* | 0.07* | 0.05* | 0.03* | 0.07* | 0.05* | 0.03* | 0.02* | -0.04* | -0.03* | -0.04* | -0.07* | - | - | - | - | - | - | - | - | - |
Net Income | -49.5% | 20.00 | 40.00 | 56.00 | 51.00 | -0.25 | -6.65 | 28.00 | 121 | -57.90 | -36.49 | 13.00 | 17.00 | 17.00 | 785 | -29.18 | 81.00 | 15.00 | 55.00 | -37.43 | -56.47 | -3.65 |
Net Income Margin | 8.9% | 0.07* | 0.06* | 0.04* | 0.03* | 0.07* | 0.04* | 0.03* | 0.02* | -0.03* | 0.01* | 0.43* | 0.43* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -101.3% | -1.43 | 114 | 48.00 | -98.39 | -28.90 | 129 | 29.00 | -74.25 | -17.56 | 78.00 | 60.00 | 88.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 1.2% | 6,842 | 6,758 | 6,563 | 6,434 | 6,375 | 6,264 | 6,146 | 6,063 | 6,005 | 5,977 | 5,898 | 5,805 | 5,848 | 6,158 | 5,302 | 4,723 | 4,690 | 4,558 | 4,393 | 4,435 | 4,427 |
Current Assets | 0.0% | 2,956 | 2,955 | 2,950 | 2,842 | 2,751 | 2,683 | 2,518 | 2,394 | 2,274 | 2,312 | 2,358 | 2,289 | 2,342 | 2,739 | 2,648 | 2,116 | 1,942 | 1,859 | 1,807 | 1,917 | 2,056 |
Cash Equivalents | -3.9% | 755 | 785 | 694 | 580 | 725 | 762 | 620 | 605 | 587 | 617 | 642 | 667 | 649 | 1,016 | 819 | 477 | 437 | 423 | 308 | 364 | 494 |
Inventory | 7.3% | 1,107 | 1,032 | 976 | 919 | 894 | 839 | 802 | 786 | 777 | 749 | 711 | 714 | 699 | 701 | 744 | 706 | 680 | 609 | 579 | 535 | 531 |
Net PPE | -0.1% | 1,066 | 1,067 | 1,067 | 1,068 | 1,073 | 1,052 | 1,049 | 1,040 | 1,035 | 1,025 | 1,027 | 1,022 | 1,032 | 1,015 | 1,011 | 1,010 | 1,011 | 969 | 963 | 952 | 949 |
Goodwill | 0% | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 197 | 197 | 197 | 197 | 197 |
Liabilities | 1.5% | 1,890 | 1,861 | 1,780 | 1,775 | 1,772 | 1,696 | 1,641 | 1,671 | 1,739 | 1,711 | 1,657 | 1,643 | 1,742 | 2,104 | 2,065 | 1,483 | 1,568 | 1,484 | 1,432 | 1,499 | 1,459 |
Current Liabilities | 1.2% | 1,177 | 1,163 | 597 | 598 | 589 | 521 | 465 | 490 | 546 | 515 | 443 | 430 | 493 | 855 | 813 | 820 | 933 | 494 | 439 | 501 | 523 |
Long Term Debt | 0.1% | 593 | 593 | 1,085 | 1,084 | 1,083 | 1,082 | 1,081 | 1,080 | 1,079 | 1,078 | 1,077 | 1,076 | 1,075 | 1,074 | 1,073 | 487 | 486 | 844 | 839 | 835 | 830 |
LT Debt, Current | 0.1% | 494 | 493 | - | - | - | - | - | - | - | - | - | - | - | 374 | 370 | 366 | 362 | - | - | - | - |
LT Debt, Non Current | 0.1% | 593 | 593 | 1,085 | 1,084 | 1,083 | 1,082 | 1,081 | 1,080 | 1,079 | 1,078 | 1,077 | 1,076 | 1,075 | 1,074 | 1,073 | 487 | 486 | 844 | 839 | 835 | 830 |
Shareholder's Equity | 1.1% | 4,952 | 4,897 | 4,783 | 4,659 | 4,603 | 4,569 | 4,500 | 4,386 | 4,266 | 4,261 | 4,237 | 4,162 | 4,101 | 4,054 | 3,237 | 3,240 | 3,122 | 3,074 | 2,961 | 2,937 | 2,968 |
Retained Earnings | 3.2% | -621 | -641 | -682 | -738 | -789 | -788 | -777 | -804 | -930 | -867 | -831 | -844 | -861 | -883 | -1,668 | -1,639 | -1,720 | -1,735 | -1,790 | -1,753 | -1,694 |
Additional Paid-In Capital | 1.2% | 5,612 | 5,543 | 5,494 | 5,418 | 5,405 | 5,336 | 5,273 | 5,206 | 5,192 | 5,134 | 5,084 | 5,011 | 4,993 | 4,938 | 4,886 | 4,855 | 4,833 | 4,783 | 4,744 | 4,683 | 4,670 |
Accumulated Depreciation | -100.0% | - | 851 | 829 | 807 | 802 | 782 | 762 | 741 | 721 | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 0.1% | 189 | 188 | 188 | 188 | 186 | 185 | 185 | 184 | 183 | 183 | 182 | 182 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 10,100 | - | - | - | 9,000 | - | - | - | 8,400 | - | - | - | 13,900 | - | - | - | 8,100 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -79.7% | 27,483 | 135,646 | 70,062 | -73,932 | 6,786 | 158,321 | 56,226 | -45,431 | 11,180 | 97,060 | 82,784 | 113,512 | -13,384 | 86,206 | 27,737 | -15,194 | 57,343 | 70,125 | -24,338 | -54,868 | 49,374 |
Share Based Compensation | 13.4% | 54,855 | 48,387 | 50,162 | 53,695 | 46,734 | 54,663 | 47,078 | 47,833 | 43,891 | 49,026 | 54,843 | 49,503 | 47,586 | 50,169 | 44,962 | 46,994 | 38,102 | 39,173 | 39,829 | 42,761 | 36,558 |
Cashflow From Investing | -41.8% | -64,963 | -45,799 | 29,530 | -30,012 | -54,710 | -23,402 | -29,699 | 87,782 | -55,421 | -119,847 | -120,257 | -70,788 | 11,027 | 106,699 | -248,751 | 77,404 | -48,896 | 48,678 | 19,671 | -50,479 | -70,963 |
Cashflow From Financing | 1475.6% | 10,840 | -788 | 11,963 | -40,742 | 10,869 | 7,541 | -11,780 | -25,280 | 14,396 | -1,031 | 10,951 | -24,364 | -366,155 | 3,256 | 563,688 | -19,671 | 4,042 | -1,975 | -51,760 | -24,981 | -366,362 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50,000 | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
REVENUES: | |||
Total revenues | $ 2,419,226 | $ 2,096,039 | $ 1,846,275 |
OPERATING EXPENSES: | |||
Cost of sales | 514,854 | 483,669 | 470,515 |
Research and development | 746,773 | 649,606 | 628,793 |
Selling, general and administrative | 937,291 | 854,009 | 759,375 |
Intangible asset amortization and contingent consideration | 62,211 | 67,193 | 69,933 |
Gain on sale of nonfinancial assets, net | 0 | (108,000) | 0 |
Total operating expenses | 2,261,129 | 1,946,477 | 1,928,616 |
INCOME (LOSS) FROM OPERATIONS | 158,097 | 149,562 | (82,341) |
Interest income | 58,339 | 18,034 | 10,482 |
Interest expense | (17,335) | (15,970) | (15,337) |
Other income (expense), net | (10,538) | (2,050) | 11,846 |
INCOME (LOSS) BEFORE INCOME TAXES | 188,563 | 149,576 | (75,350) |
Provision for (benefit from) income taxes | 20,918 | 8,015 | (11,270) |
NET INCOME (LOSS) | $ 167,645 | $ 141,561 | $ (64,080) |
EARNINGS (LOSS) PER SHARE, BASIC (in dollars per share) | $ 0.89 | $ 0.76 | $ (0.35) |
EARNINGS (LOSS) PER SHARE, DILUTED (in dollars per share) | $ 0.87 | $ 0.75 | $ (0.35) |
Weighted-average common shares outstanding, basic (in shares) | 187,834 | 185,266 | 182,852 |
Weighted average common shares outstanding, diluted (in shares) | 191,595 | 188,963 | 182,852 |
Net product revenues | |||
REVENUES: | |||
Total revenues | $ 2,372,538 | $ 2,042,025 | $ 1,783,498 |
Royalty and other revenues | |||
REVENUES: | |||
Total revenues | $ 46,688 | $ 54,014 | $ 62,777 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 755,127 | $ 724,531 |
Short-term investments | 318,683 | 567,006 |
Accounts receivable, net | 633,704 | 461,316 |
Inventory | 1,107,183 | 894,083 |
Other current assets | 141,391 | 104,521 |
Total current assets | 2,956,088 | 2,751,457 |
Noncurrent assets: | ||
Long-term investments | 611,135 | 333,835 |
Property, plant and equipment, net | 1,066,133 | 1,073,366 |
Intangible assets, net | 294,701 | 338,569 |
Goodwill | 196,199 | 196,199 |
Deferred tax assets | 1,545,809 | 1,505,412 |
Other assets | 171,538 | 176,236 |
Total assets | 6,841,603 | 6,375,074 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 683,147 | 572,959 |
Short-term convertible debt, net | 493,877 | 0 |
Short-term contingent consideration | 0 | 15,925 |
Total current liabilities | 1,177,024 | 588,884 |
Noncurrent liabilities: | ||
Long-term convertible debt, net | 593,095 | 1,083,019 |
Other long-term liabilities | 119,935 | 100,015 |
Total liabilities | 1,890,054 | 1,771,918 |
Stockholders’ equity: | ||
Common stock, $0.001 par value: 500,000,000 shares authorized; 188,598,154 and 186,250,719 shares issued and outstanding, respectively | 189 | 186 |
Additional paid-in capital | 5,611,562 | 5,404,895 |
Company common stock held by the Nonqualified Deferred Compensation Plan | (9,860) | (8,859) |
Accumulated other comprehensive loss | (28,788) | (3,867) |
Accumulated deficit | (621,554) | (789,199) |
Total stockholders’ equity | 4,951,549 | 4,603,156 |
Total liabilities and stockholders’ equity | $ 6,841,603 | $ 6,375,074 |